成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國(guó)籍:中國(guó)
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11974
93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

IL-17A antagonist 1 IL-17A antagonist 1 2205034-18-8
TLR7/8-IN-1 TLR7/8-IN-1 2205095-75-4
Simazine-d5 西瑪津-D5 220621-41-0
Ruplizumab RUPLIZUMAB 220651-94-5
Sasanlimab SASANLIMAB (薩善利單抗 ) 2206792-50-7
Ragifilimab 拉格芙利單抗 2207590-51-8
RO0270608 (S)-2-(2-氯-6-甲基苯甲酰氨基)-3-(4-(2,6-二氯苯甲酰氨基)苯基)丙酸 220846-33-3
MMV688845 (R)-GSK1729177A 2208962-35-8
4,4-Diphenylbutylamine hydrochloride 4,4-二苯基丁胺(鹽酸鹽) 22101-90-2
Crobenetine 克羅奈汀 221019-25-6
Mal-amide-PEG8-Val-Ala-PAB-PNP L-ALANINAMIDE, N-[31-(2,5-DIHYDRO-2,5-DIOXO-1H-PYRROL-1-YL)-1,29-DIOXO-4,7,10,13,16,19,22,25-OCTAOXA-28-AZAHENTRIACONT-1-YL]-L-VALYL-N-[4-[[[(4-NITROPHENOXY)CAR 2210247-59-7
(S)-Desmethyl-NNC112 (+)-DESMETHYL-NNC112 221132-62-3
Nec-34i 2-((3-氰基-6-氧代-4-(對(duì)甲苯基)-1,4,5,6-四氫吡啶-2-基)硫基)-N-苯基乙酰胺 2212541-00-7
Petosemtamab PETOSEMTAMAB (派森妥單抗 ) 2213450-26-9
AZD8154 AZD8154 2215022-45-8
K-111 化合物 T27706 221564-97-2
SCH 57790 化合物 T28722 221660-80-6
Cosibelimab COSIBELIMAB (柯希利單抗 ) 2216751-26-5
Benzyl-PEG12-alcohol 十二甘醇單芐醚 2218463-17-1
TZ3O 化合物 TZ3O 2218754-19-7
Tuberculosis inhibitor 3 TUBERCULOSIS INHIBITOR 3 2219325-28-5
SARS-CoV-2-IN-14 5-氯-N-(3-氯苯基)-2-羥基苯甲酰胺 22203-98-1
MI-389 化合物 T33380 2222635-92-7
Tafolecimab TAFOLECIMAB (托萊西單抗 ) 2225109-03-3
Gemnelatinib GEMNELATINIB 2225123-30-6
PARP10-IN-3 化合物PARP10-IN-3 2225800-19-9
Zelminemab ZELMINEMAB (澤米奈單抗 ) 2225850-33-7
RO7185876 (S)-N-[(1R,5S,8S)-3-(6-甲基-4-嘧啶基)-3-氮雜雙環(huán)[3.2.1]辛烷-8-基]-9-(2,3,4-三氟苯基)-6,7,8,9-四氫-5H-[1,2,4]三唑并[1,5-A]氮雜卓-2-胺 2226038-71-5
Talquetamab 塔奎妥單抗 2226212-40-2
Tinurilimab 替奴瑞利單抗 2226224-30-0
Bamocaftor 2204245-48-5 2204245-48-5
MY10 化合物 MY10 2204270-73-3
MY33-3 MY33-3 2204280-41-9
MY33-3 hydrochloride MY33-3(鹽酸鹽) 2204280-42-0
Pexelizumab h5G1.1-scFv 219685-93-5
Felzartamab 菲澤妥單抗 2197112-39-1
Visilizumab VISILIZUMAB 219716-33-3
Pramiconazole PRAMICONAZOLE 219923-85-0
Zagociguat ZAGOCIGUAT 2201048-82-8
(S)-HH2853 化合物 (S)-HH2853 2202678-05-3
(R)-HH2853 化合物 (R)-HH2853 2202678-06-4
ALDH1A2-IN-1 ALDH1A2-IN-1 2204229-64-9
ATG7-IN-2 化合物 ATG7-IN-2 2226227-75-2
Avdoralimab AVDORALIMAB (艾朵利單抗 ) 2226393-85-5
2'-O-(2-Azidoethyl)adenosine 2'-O-(2-Cyanoethyl)adenosine 2226475-42-7
NV-5440 化合物 NV-5440 2226614-88-4
AVG-233 化合物 AVG-233 2151937-80-1
Propionanilide, 3'-hydroxy- N-(3-HYDROXYPHENYL)PROPANAMIDE 21556-86-5
Axatilimab AXATILIMAB (艾克利單抗 ) 2155851-88-8
Benproperine 苯丙哌林 2156-27-6
Befovacimab BEFOVACIMAB (貝弗西單抗 ) 2156634-62-5
CCCI-01 5-Nitro-N-(3-pyridinylmethyl)-2-furancarboxamide 215778-97-5
(R)-GSK-3685032 BENZENEACETAMIDE, Α-[[6-(4-AMINO-1-PIPERIDINYL)-3,5-DICYANO-4-ETHYL-2-PYRIDINYL]THIO]-, (ΑR)- 2170140-50-6
IRAK4-IN-21 化合物 IRAK4-IN-21 2170694-04-7
IRAK4-IN-22 化合物 IRAK4-IN-22 2170694-05-8
Bedinvetmab BEDINVETMAB (貝汀維單抗 ) 2171034-69-6
Relfovetmab RELFOVETMAB (瑞弗維單抗 ) 2171034-70-9
Dovanvetmab DOVANVETMAB (度伐維單抗 ) 2171034-71-0
Nidanilimab NIDANILIMAB (尼達(dá)利單抗 ) 2171061-85-9
AKOS037652256 N1-(2-(4-(4-chloro-2-fluorophenyl)piperazin-1-yl)phenyl)-N4,N4-dimethylbenzene-1,4-disulfonamide 2171065-77-1
Arg-Gly-Asp-Cys TFA (6S,12S,15R)-1,6-二氨基-12-(羧甲基)-1-亞氨基-15-(巰基甲基)-7,10,13-三氧代-2,8,11,14-四氮雜十六烷-16-酸 三氟乙酸鹽 2171504-22-4
Indole-C2-amide-C2-NH2 化合物 INDOLE-C2-AMIDE-C2-NH2 215789-29-0
Chst15-IN-1 Sulfotransferase-IN-1 2158198-77-5
Navocaftor NAVOCAFTOR 2159103-66-7
Semorinemab SEMORINEMAB (西瑞奈單抗 ) 2159141-27-0
Elsibucol ELSIBUCOL 216167-95-2
Garadacimab GARADACIMAB (加達(dá)西單抗 ) 2162134-62-3
Sonlicromanol hydrochloride SONLICROMANOL HYDROCHLORIDE 2162149-24-6
DBCO-PEG3-NHS ester 二苯并環(huán)辛炔-三聚乙二醇-NHS酯 2163772-16-3
Mitumomab Mitumomab 216503-58-1
Glucocorticoid receptor agonist-1 GLUCOCORTICOID RECEPTOR AGONIST-1 2166375-82-0
Sibrotuzumab Sibrotuzumab 216669-97-5
Nurulimab NURULIMAB (諾瑞利單抗 ) 2168561-20-2
Manelimab MANELIMAB (瑪奈利單抗 ) 2168561-26-8
L 756423 化合物 T24362 216863-66-0
SHP2-IN-6 hydrochloride SHP2-IN-6 HYDROCHLORIDE 2169223-49-6
Magrolimab MAGROLIMAB (莫洛利單抗 ) 2169232-81-7
Thalidomide-O-C6-COOH Heptanoic acid, 7-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]- 2169266-69-5
KDM2A/7A-IN-1 KDM2A/7A-IN-1 2169272-46-0
Atinvicitinib 1-[(3R,4S)-4-CYANOTETRAHYDRO-2H-PYRAN-3-YL]-3-[(2-FLUORO-6-METHOXY-4-PYRIDINYL)AMINO]-1H-PYRAZOLE-4-CARBOXAMIDE 2169273-59-8
SOCE inhibitor 1 SOCE inhibitor 1 2169316-15-6
Zanidatamab ZANIDATAMAB (澤尼達(dá)妥單抗 ) 2169946-15-8
Amivantamab AMIVANTAMAB (埃萬(wàn)妥單抗 ) 2171511-58-1
(S,R,S)-AHPC-CO-C9-acid MDN19780 2172819-78-0
Astegolimab ASTEGOLIMAB (艾特利單抗 ) 2173054-79-8
Encelimab ENCELIMAB (安沙利單抗 ) 2173096-82-5
INCB-000928 化合物 ZILURGISERTIB 2173389-57-4
Cytembena Sodium 21739-91-3
L-796,778 化合物 T32511 217480-25-6
Monuron-d6 滅草隆-D6 217488-65-8
Tau-aggregation and neuroinflammation-IN-1 化合物 TAU-AGGREGATION AND NEUROINFLAMMATION-IN-1 2175953-98-5
TLR7 agonist 1 TLR7 agonist 1 2178156-33-5
Lenalidomide-PEG1-azide 化合物 LENALIDOMIDE-PEG1-AZIDE 2185795-67-7
Disitamab DISITAMAB (迪西妥單抗 ) 2185868-98-6
Lacutamab LACUTAMAB (拉可妥單抗 ) 2187368-16-5
Batoclimab 巴托利單抗 2187430-05-1
LTβR-IN-1 Compound 919278 2189366-77-4
PSMA I&T PSMA I&T 2192281-54-0
Metronidazole-hydroxy-d2 羥基甲硝唑-D2 2196180-19-3
Labetuzumab Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer 219649-07-7
93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.